RPG Life Sciences Limited

NSEI:RPGLIFE Stock Report

Market Cap: ₹32.9b

RPG Life Sciences Past Earnings Performance

Past criteria checks 1/6

RPG Life Sciences has been growing earnings at an average annual rate of 24.2%, while the Pharmaceuticals industry saw earnings growing at 13.3% annually. Revenues have been growing at an average rate of 12% per year. RPG Life Sciences's return on equity is 18.6%, and it has net margins of 11.4%.

Key information

24.2%

Earnings growth rate

24.2%

EPS growth rate

Pharmaceuticals Industry Growth17.5%
Revenue growth rate12.0%
Return on equity18.6%
Net Margin11.4%
Last Earnings Update30 Sep 2024

Recent past performance updates

There May Be Some Bright Spots In RPG Life Sciences' (NSE:RPGLIFE) Earnings

Nov 15
There May Be Some Bright Spots In RPG Life Sciences' (NSE:RPGLIFE) Earnings

RPG Life Sciences' (NSE:RPGLIFE) Earnings Are Of Questionable Quality

May 08
RPG Life Sciences' (NSE:RPGLIFE) Earnings Are Of Questionable Quality

Recent updates

There May Be Some Bright Spots In RPG Life Sciences' (NSE:RPGLIFE) Earnings

Nov 15
There May Be Some Bright Spots In RPG Life Sciences' (NSE:RPGLIFE) Earnings

RPG Life Sciences Limited's (NSE:RPGLIFE) Shares Climb 26% But Its Business Is Yet to Catch Up

Oct 18
RPG Life Sciences Limited's (NSE:RPGLIFE) Shares Climb 26% But Its Business Is Yet to Catch Up

Investors Appear Satisfied With RPG Life Sciences Limited's (NSE:RPGLIFE) Prospects As Shares Rocket 30%

Jul 25
Investors Appear Satisfied With RPG Life Sciences Limited's (NSE:RPGLIFE) Prospects As Shares Rocket 30%

RPG Life Sciences' (NSE:RPGLIFE) Earnings Are Of Questionable Quality

May 08
RPG Life Sciences' (NSE:RPGLIFE) Earnings Are Of Questionable Quality

RPG Life Sciences (NSE:RPGLIFE) Is Increasing Its Dividend To ₹12.00

Jul 11
RPG Life Sciences (NSE:RPGLIFE) Is Increasing Its Dividend To ₹12.00

Estimating The Intrinsic Value Of RPG Life Sciences Limited (NSE:RPGLIFE)

Sep 05
Estimating The Intrinsic Value Of RPG Life Sciences Limited (NSE:RPGLIFE)

Shareholders May Be More Conservative With RPG Life Sciences Limited's (NSE:RPGLIFE) CEO Compensation For Now

Aug 24
Shareholders May Be More Conservative With RPG Life Sciences Limited's (NSE:RPGLIFE) CEO Compensation For Now

A Look At The Intrinsic Value Of RPG Life Sciences Limited (NSE:RPGLIFE)

Jun 14
A Look At The Intrinsic Value Of RPG Life Sciences Limited (NSE:RPGLIFE)

Are Strong Financial Prospects The Force That Is Driving The Momentum In RPG Life Sciences Limited's NSE:RPGLIFE) Stock?

Feb 09
Are Strong Financial Prospects The Force That Is Driving The Momentum In RPG Life Sciences Limited's NSE:RPGLIFE) Stock?

Can You Imagine How RPG Life Sciences' (NSE:RPGLIFE) Shareholders Feel About The 75% Share Price Increase?

Jan 13
Can You Imagine How RPG Life Sciences' (NSE:RPGLIFE) Shareholders Feel About The 75% Share Price Increase?

RPG Life Sciences (NSE:RPGLIFE) Is Growing Earnings But Are They A Good Guide?

Dec 23
RPG Life Sciences (NSE:RPGLIFE) Is Growing Earnings But Are They A Good Guide?

Declining Stock and Solid Fundamentals: Is The Market Wrong About RPG Life Sciences Limited (NSE:RPGLIFE)?

Nov 11
Declining Stock and Solid Fundamentals: Is The Market Wrong About RPG Life Sciences Limited (NSE:RPGLIFE)?

Estimating The Fair Value Of RPG Life Sciences Limited (NSE:RPGLIFE)

Oct 21
Estimating The Fair Value Of RPG Life Sciences Limited (NSE:RPGLIFE)

Did Business Growth Power RPG Life Sciences' (NSE:RPGLIFE) Share Price Gain of 126%?

Sep 28
Did Business Growth Power RPG Life Sciences' (NSE:RPGLIFE) Share Price Gain of 126%?

What Makes RPG Life Sciences Limited (NSE:RPGLIFE) A Great Dividend Stock?

Aug 31
What Makes RPG Life Sciences Limited (NSE:RPGLIFE) A Great Dividend Stock?

With RPG Life Sciences Limited (NSE:RPGLIFE) It Looks Like You'll Get What You Pay For

Aug 11
With RPG Life Sciences Limited (NSE:RPGLIFE) It Looks Like You'll Get What You Pay For

What You Can Learn From RPG Life Sciences Limited's (NSE:RPGLIFE) P/E

Jul 28
What You Can Learn From RPG Life Sciences Limited's (NSE:RPGLIFE) P/E

Calculating The Intrinsic Value Of RPG Life Sciences Limited (NSE:RPGLIFE)

Jul 10
Calculating The Intrinsic Value Of RPG Life Sciences Limited (NSE:RPGLIFE)

Revenue & Expenses Breakdown

How RPG Life Sciences makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NSEI:RPGLIFE Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 246,1837071,5360
30 Jun 245,9979231,5410
31 Mar 245,8218771,5420
31 Dec 235,7368481,5130
30 Sep 235,5057741,4590
30 Jun 235,3177151,4030
31 Mar 235,1286761,3460
31 Dec 224,9816481,2370
30 Sep 224,8316031,2090
30 Jun 224,6105611,1880
31 Mar 224,4025151,1530
31 Dec 214,2915091,0580
30 Sep 214,2114911,0460
30 Jun 214,0564459520
31 Mar 213,8914001,0550
31 Dec 203,8513611,0800
30 Sep 203,7183111,0650
30 Jun 203,7322971,0550
31 Mar 203,7562909930
31 Dec 193,5572761,0100
30 Sep 193,5232491,0080
30 Jun 193,4431739970
31 Mar 193,3021089880
31 Dec 183,4481051,0560
30 Sep 183,4951071,0480
30 Jun 183,4851491,0270
31 Mar 183,4401351,0090
31 Dec 173,3601418700
30 Sep 173,062978330
30 Jun 172,948628010
31 Mar 172,9361218350
31 Dec 163,0292297840
30 Sep 163,0952707890
30 Jun 162,9931947820
31 Mar 162,552846960
31 Dec 152,7581411,0400
30 Sep 152,6091199660
30 Jun 152,501209780
31 Mar 152,423106860
31 Dec 142,290-429280
30 Sep 142,273-981,0190
30 Jun 142,312-16990
31 Mar 142,3565349930
31 Dec 132,4006139690

Quality Earnings: RPGLIFE has a large one-off loss of ₹262.4M impacting its last 12 months of financial results to 30th September, 2024.

Growing Profit Margin: RPGLIFE's current net profit margins (11.4%) are lower than last year (14.1%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: RPGLIFE's earnings have grown significantly by 24.2% per year over the past 5 years.

Accelerating Growth: RPGLIFE's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: RPGLIFE had negative earnings growth (-8.7%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (20.5%).


Return on Equity

High ROE: RPGLIFE's Return on Equity (18.6%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies